Buprenorphine deaths stay low regardless of elevated entry

The onset of the Covid-19 pandemic led to a sea change in dependancy medication — specifically, elevated entry to buprenorphine, a drug generally used to deal with opioid use dysfunction.

Now, new knowledge present that regardless of the treatment’s wider availability, deaths involving buprenorphine nonetheless represent a small fraction of general drug mortality.

The research, printed Friday in JAMA Community Open, gives new perception into the affect of emergency insurance policies enacted in early 2020 to sluggish Covid’s unfold whereas preserving entry to dependancy care. The adjustments allowed medical doctors to subject new buprenorphine prescriptions by way of telemedicine, making the treatment way more accessible for sufferers in rural areas or with out entry to transportation.

commercial

Buprenorphine, nevertheless, is itself an opioid, and is regulated as a managed substance. Whereas most medical doctors and well being officers welcomed the adjustments, a small minority expressed concern that rising buprenorphine entry might have unintended penalties.

These considerations had been largely unfounded, in accordance with the brand new analysis, which was authored by high dependancy researchers on the Facilities for Illness Management and Prevention and the Nationwide Institute on Drug Abuse.

commercial

Whereas deaths involving buprenorphine did tick upward within the months following the coverage adjustments, they elevated at a considerably decrease charge than general drug deaths. Between July 2019 and June 2021, the share of opioid-related deaths involving buprenorphine dropped from 3.6% to 2.1%.

Amongst those that died of buprenorphine-involved overdoses, simply 20% had been particularly receiving medicines used to deal with opioid use dysfunction, which means the drug was possible acquired illegally.

Extra broadly, practically 93% of deaths involving buprenorphine additionally concerned different substances, which means that fewer than 1 in 600 opioid-involved deaths is attributable to buprenorphine alone.

The examine’s publication comes amid a broader motion to extend entry to dependancy medicines. In December, Congress handed laws eliminating a requirement that medical doctors wishing to prescribe the treatment receive a particular license referred to as an “X-waiver.”

Federal regulators additionally introduced plans to make the emergency telehealth provisions enacted in 2020 everlasting. As well as, Covid-era guidelines permitting sufferers to take dwelling weeks’ value of methadone, one other frequent and extremely efficient therapy for opioid dependancy, will even change into everlasting. An analogous examine printed final 12 months confirmed that methadone-related deaths didn’t enhance regardless of the brand new flexibilities.

Nonetheless, entry to buprenorphine isn’t with out its challenges. Some pharmacies have reported that the Drug Enforcement Administration nonetheless conducts raids on amenities filling telemedicine prescriptions for buprenorphine, regardless of the brand new guidelines.

Individually, medical doctors throughout the U.S. have reported elevated issue with buprenorphine “inductions,” or the method of giving sufferers their first dose. Because the drug provide has change into extra contaminated by fentanyl, buprenorphine has change into extra prone to trigger extreme withdrawal signs, main sufferers to hunt therapy utilizing alternate options like methadone — or keep away from therapy altogether.

STAT’s protection of continual well being points is supported by a grant from Bloomberg Philanthropies. Our monetary supporters are usually not concerned in any selections about our journalism.

Get your day by day dose of well being and medication each weekday with STAT’s free e-newsletter Morning Rounds. Enroll right here.